SD

Seema Kulthe Dattatraya - Profile

Seema Kulthe Dattatraya, Additional Director and Director, with 3 companies.

About Seema Kulthe Dattatraya

Seema Kulthe Dattatraya has 9 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Atlaseva Solutions And Projects Private Limited and Zyshak Pharmaceuticals Private Limited. Formerly with 1 company, such as Elder Neutraciticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 2
Past Companies 1
Total Affiliations 3
Oldest Company Age 10
Companies Associated with Seema Kulthe Dattatraya
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Seema Kulthe Dattatraya?

Seema Kulthe Dattatraya has 9 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Atlaseva Solutions And Projects Private Limited and Zyshak Pharmaceuticals Private Limited. Formerly with 1 company, such as Elder Neutraciticals Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Seema Kulthe Dattatraya's role in current companies?

Seema Kulthe Dattatraya is associated with 2 companies as Additional Director and Director.

What industries does Seema Kulthe Dattatraya specialize in?

Seema Kulthe Dattatraya has expertise in General Business.

How many years of experience does Seema Kulthe Dattatraya have?

Seema Kulthe Dattatraya has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available